Simultaneous Analysis of Anti-Hypertensive Drugs by RP-HPLC: An Overview
DOI:
https://doi.org/10.22270/ajprd.v12i1.1355Keywords:
bbbbbbbbbbbbbbbbbAbstract
High performance liquid chromatography (HPLC) is an important qualitative and quantitative technique, generally used for the estimation of pharmaceutical and biological samples. In now a day pharmaceutical market, many newer antihypertensive combination drugs are available to control hypertension as well as to keep society healthy and stress free. All presently available old drugs have frequent dosing produces various side effects. So, there is need to analyse such antihypertensive drugs. The aim of this review is to analysed such commonly used antihypertensive combination drugs by using reverse phase high performance liquid chromatography (RP-HPLC). Reversed-phase high-performance liquid chromatography (RP-HPLC) involves the separation of molecules on the basis of hydrophobicity. The separation depends on the hydrophobic binding of the solute molecule from the mobile phase to the immobilized hydrophobic ligands attached to the stationary phase. The drugs like Amlodipine besylate and Valsartan, Irbesartan and Hydrochlorothiazide, Atenolol and Chlorthalidone, Hydrochlorothiazide and Candesartan, Ramipril and Amlodipine, Hydrochlorothiazide and Enalapril, Quinapril and Hydrochlorothiazide etc. About fifteen combination drugs are analysed by using RP-HPLC. This review assists in appropriate selection of column, mobile phase, pH, flow rate, detector and form of such combination drugs.
Downloads
References
Martin M, Guiochon G. Effects of high pressures in liquid chromatography. J. Chromatogr. Anal. 2005;(1-2)7:16-38
Liu Y, Lee ML. Ultrahigh pressure liquid chromatography using elevated temperature. J.Chromatogr.2006;1104(1-2):198–202
AbidiSL. High-performance liquid chromatography of phosphatidic acids and relatedpolar lipids. J. Chromatogr.1991; 587:193-203
Hearn MT. Ion-pair chromatography on normal and reversed-phase systems. Adv. Chromatogr.1980; 18:59–100
Tripathi KD. Essentialsof medicalpharmacology.Sixth edition,Jaypee Brothers Medical Publishers (P) Ltd. New Delhi, 2003;539-540
WHO Hypertension- https://www.int/news-roo/factsheet/detail/hypertension (Accessed in November 2021)
Combination drug- https://www.fda.gov/consumer/free-publication-women/high-blood-pressure#ACE-inhibitors
Rahul RN, Joshi SS, VershaM,Shabtr N.Stability indicating RP-HPLC method for simultaneous determination of amlodipine besylate and combination in bulk and commercial dosage form.Asian J. of Pharm and life Sci.2012;2(2):280-290
DyadeGK,SawankRL. ValidatedRP-HPLC method and unique mobile phase for the simultaneous estimation of amlodipine besylate and valsartan from solid dosage form bulk and rosuvastatin&valsartan. Asian J. Pharm Chem.2018;1(6):31-36
Patel BS, Choudhury BG,Buch M,Patel AB. StabilityindicatingRP-HPLCmethod for simultaneous determination ofvalsartan&amlodipine from their Combination dosageform.Int. J.Chemtech. 2019;1(4):1257 – 1267
Ali TA,Mohamed GG, AliAA, TaibFH. RP-HPLC stability indicating method for estimation irbesartan and hydrochlorothiazide in bulk and pharmaceutical dosage form. Chinese J. Anal.Chem.2016;4(1):1601-1608
Esward M,Chary T, JunapudiS, Sharma M. RP-HPLC method development and validation for simultaneousestimation ofirbesartan&hydrochlorothiazide in pharmaceutical dosage form. Asian J. ResChem. 2012;5(4):348-352
Ravishankar P, Rao G, Sreevidya V.Novel RP-HPLC method for simultaneous determination of irbesartan and hydrochlorothiazide in bulk and tablet dosage form. Science spectrum.2016;1(3):309-330
Kumar GS, Ramya V,Mondal S, Kumar SP. Devlopement and validation of RP-HPLC method for simultaneous estimation of atenolol and chlorthalidone from pharmaceutical formulation. Int.Res J.Pharm.2012;3(10):215-218
Devi AL, Sree GU, Rao UM. A New RP-HPLC method development& validation for the dissolution studies ofatenelol&chlorthalidoneimmediate Release Tablet dosage form.Int.J.ResPharma&Chem.2014;4(4):958 – 965
Devi RG, NagarajunK. Analytical method development and validation for the estimation of chlorthalidone and atenolol by RP-HPLC. Int.J.AdvRes and Develop.2018;3(10): 133:137
Bonthu MG,AtmakuriLR,Jangala VR. Simultaneous determination of candesartan and hydrochlorothiazide in human plasma by LC-MS/MS.Brazilian J. PharmaSci.2018; 54(1): e17381
Madhavi K, Navamani M, Prasanthi C.Simple analytical method for the simtameous estimation hydrochlorthazide&condesartan by RP-HPLC. Int.J.Applied Pharma.2017; 9(6):35-37
Shrikalyani V, Madhuri T,Sareesh K, Kumar M. Simultaneous estimation of hydrochlorothiazide and condesartan in bulk and pharmaceutical dosage form by RP-HPLC PDA method. Int. J.PharmSci&Res.2018;9(1):150-157
Kotthiredddy K,Rama Devi B. Stability indicating RP-HPLC method development and validation for the simultaneous estimation of condesartancilexeotiland hydrochlorothiazide in bulk and tablet dosage form. Scholar’s researchlibrary.2015;7(12):114-121
Dai SY,Qiu ST,Wu W, Fu CM. Development and validation of an RP-HPLC method for simultaneous determination of ramipril and amlodipine in tablets. J.PharmaAnal.2013;3(6):440–446
AnandBK,Kumar GV,Sivasubramanian L. Simultaneous estimation oframipril and amlodipine in pharmaceutical dosage form by RP-HPLC method. Int.J.PharmaSci. 2014; 3(4):196-198
Rajput PS,Kaur A,Gill NK. Simultaneous estimation of ramipril and amlodipine in bulk and tablet dosage form by RP-HPLC method. J.Applied PharmaSci. 2012;2(7):160-165
Hammouda M, Mohamed A, Abu EE, Dina TE, Dalia R,SaadiaMA.Simultaneous Determination of enalapril and hydrochlorothiazide in Pharmaceutical Preparations Using Microemulsion Liquid Chromatography.J.Chromatogra.Sci. 2015; 53:90–96
SurydevaraV, RaoBV, Koduri T, Adimulan LR. Analytical method development and validation for simultaneous estimation of enalapril maleate and hydrochlorothiazide by RP-HPLC. Der Pharma Chemica.2014;6(1):217-223
Foda NH,Naeem O,AbdELbary A. Simultaneous HPLC determination of Enalapril and Hydrochlorothiazide in human plasma and its pharmacokinetics application. J. Pharm Sci&Res.2012;2(11):786-794
Keerthi J,SubramaniyanD. Analytical method development and validation for the simultaneous estimation of enalapril and hydrochlorothiazide by RP-HPLC method in bulk and pharmaceutical dosage form.J.PharmAnal.2019;1(12):323-332
Prameela KL,Veni R,SatyanarayanaP,Babu BH. Stability indicating reverse phase high performance liquid chromatographic method with photodiode array detection for the simultaneous quantification of quinapril and hydrochlorthiazide in bulk and tablet dosage forms.Asian J.Chem.2018;30(4):873-878
Rani GS, Gandhi MB,Kumar GM,Rekha M,PullamKR. A new RP-HPLC method for simultaneous estimation of quinapril and hydrochlorothiazide in pharmaceutical dosage form. World J.PharmSci. 2013;2(6):6220-6234
AltunsoyS, Bonzal B.Validation of liquid chromatography method for simultaneous determination of quinapril and hydrochlorothiazide in pharmaceutical dosage form. Turk j.Pharm Sci. 2013;10(2):255-262
Megala K, Chenthilnathan A,Sathishbabu A. Validated RP-HPLC method for simultaneous determination of telmisartan and hydrochlorothiazide in pharmaceutical formulation.Int. J.PharmRes & Allied Sci.2014;3(3):33-40
Wankhede SB,TajaneMR,Gupta KR,Wadodkar SG. RP-HPLC method for simultaneous estimation of telmisartan and hydrochlorothiazide in tablet dosage form. Indian J.PharmaSci. 2007;69(2):298-300
Mukhopodhyay S, Kadam K,Sawant L, Nachane D,PanditaN. Simultaneous determination of related substances of telmisartan and hydrochlorothiazide in tablet dosage form by using RP-HPLC method. Indian J.PharmaSci. 2011;3(3):375-383
Aher SS, Saudagar RB,Kothar H. Devlopement and validation of RP-HPLC method for simultaneous estimation of azilsartanmedoxomil and chlorthalidone in bulk and tablet dosage form.Int.J. Current PharmaRes.2018;10(6):22-23
Naazneen S,Sridevi A. Stability indicating RP-HPLC method for the simultaneous estimation of azilsartanmedoxomil and chlorthalidone in solid dosage form. Int.J.Pharmacy&PharmSci.2014;6(6):237-242
Sohani SK,Kumar R,Akhtar M,Chanda R, Chawala G. Development and validation of RP-HPLC method for simultaneous estimation of azilsartan and chlorthalidone in bulk form and formulation using quality by design. Int.J.Pharm &Sci.2016;8(2):267-271
Huang T,He Z, Yang B,Shao L,Zheng X,Duan G. Simultaneous determination of captopril and hydrochlorothiazide in human plasma by reverse-phase HPLC from linear gradient elution. J.Pharm&BiomedAnal.2006; 41:644–648
Veerubhotia K, Walker RB. Development and validation of stability indicating RP-HPLC method using quality by design for estimation captopril. Indian J. of PharmSci. 2019;81(1): 45-56
Ivanovic D,Medenica M,Malenovic A,Jancic B.Validation of the RP-HPLC method for analysis of hydrochlorothiazide and captopril in tablet. AccredQual Assur.2004; 9:76-81
HossenA,Haque A,Dewan I,Kabir H, Hossain K, Islam A. Development and validation of RP-HPLC method for the simultaneous estimation of hydrochlorothiazide and losartan potassium in tablet dosage form. DhakaUniv. J. Pharm Sci.2011;10(1):35-42
Argekar AP,Sawant JG. A gradient reversed phase HPLC method for simultaneous determination of hydrochlorothiazide and losartan potassium. Analytical Later.2008;33(5): 869-880
SibelA, Ozkan. Simultaneous determination of losartan potassium and hydrochlorothiazide from tablet and human serum by RP-HPLC. J.Liquid Chromatogr.&RelatedTechno.2007;24(15):2337-2346
Naikini P,Akula A, Ajitha A, RaoMV. RP-HPLC method development and validation for the simultaneous estimation of amlodipine and atenolol in bulk and tablet dosage form.Int.J. Pharmacy &PharmSci.2014;6(1):391-393
Phillip B, Joseph J,Pandian M.RP-HPLC development and validation for simultaneous estimation of atenelol and amlodipinebesylate in pharmaceutical dosage form. Int.J. PharmSci&Res.2016;4(1):345-355.
HaqueA,Nazin A.Development and validation of RP-HPLC method for the simultaneous estimation of atenolol and amlodipine in tablet dosage form.Dhaka Univ.J. of Pharm.Sci.2010;9(2):131-138
GanipisettyLA,Dachinamoorthy D, Rao VL. Stabilityindicating RP-HPLC method development and validation of simultaneous estimation of trandolapril and verapamil hydrochloride with forced degradation studies in bulk and commercial products.Int.J.PharmaResSchol.2015;4(4):1-8
Srilatha,Saikiran G, HemalathaR.Reverse phase high performance liquid chromatography method development and validation for the simultaneous determinationof verapamil and trandolapril in pure form and their marketed combined pharmaceutical dosage form. Int. J. Farmacia.2020;7(4):236-256
LaxmiPM, Geotha V.Devlopment and validation of RP-HPLC method for the simultaneous estimation of verapamil hydrochloride &trandolapril in bulk and pharmaceutical dosage form. Asian J.PharmAnal&MediChem.2016;4(1):38-46
Hema P, Chandra PK, Rao BA,Kumari AS. Chemometric assisted RP-HPLC quantitative estimation and validation of hydrochlorothiazide and triamterene in tablet dosage form. Int. J. Pharmacy and AnalRes.2017;6(3):442-448
SathyanaryanaP,Balaji, AnanthKR, Lakshmi K, Ashok P. Analytical method development and validation of simultaneous estimation of hydrochlorothiazide and triamterene in combined tablet dosage form by RP HPLC. Int. Res.J.Pharmacy &Pharmaco.2018;6(1):48-54
Margaryan T,Mikayelyan A,Zakaryan H,Armoudjian Y.Simultaneous determination of triamterene and hydrochlorothiazide in human plasma by liquid chromatography tandem mass spectrometry &its application to abioequivalencestudy. SN Applied Sci.2019; 1:653
NeelimaK, RajendraY. Analytical method development and validation for simultaneous estimation of hydralazine, isosorbidedinitrate in bulk and tablet formulation by RP-HPLC. Indian J.Pharm.Sci&Res.2014;5(4):1290-1294
Patel VS, Pandya SS. A review onanalytical methods for estimation ofisosorbridedinitrate&hydralazinehydrochloride in bulk and pharmaceutical dosage form. Int.J.Chem.TechRes. 2017;10(10):92-94
MastanammaSK, Saidulu P,Sravanthi A,Raijtha E. Stability indicating validated RP-HPLCmethod forsimultaneousdetermination of hydralazinehydrochloride &isosorbidedenigrate in bulk &pharmaceutical dosage form. Int. J. Pharm Sci.2018;40(1):141-148
Published
How to Cite
Issue
Section
Copyright (c) 2024 Akshay Katkale, Sagar Fodase, Ashok Pingle, Ganesh Dhikale, Pratik Waghmare, Deepak Dhake
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
.